A Phase II Study of Bevacizumab Plus Docetaxel and Gemcitabine in Subjects With Advanced, Previously Untreated, Non-Squamous Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2013
At a glance
- Drugs Bevacizumab (Primary) ; Docetaxel; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 18 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Oct 2011 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Oct 2011 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.